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Vitamin B12 (cobalamin) is required by humans and other organ-
isms for diverse metabolic processes, although only a subset of
prokaryotes is capable of synthesizing B12 and other cobamide
cofactors. The complete aerobic and anaerobic pathways for the
de novo biosynthesis of B12 are known, with the exception of the
steps leading to the anaerobic biosynthesis of the lower ligand,
5,6-dimethylbenzimidazole (DMB). Here, we report the identifica-
tion and characterization of the complete pathway for anaerobic
DMB biosynthesis. This pathway, identified in the obligate anaer-
obic bacterium Eubacterium limosum, is composed of five previ-
ously uncharacterized genes, bzaABCDE, that together direct DMB
production when expressed in anaerobically cultured Escherichia
coli. Expression of different combinations of the bza genes
revealed that 5-hydroxybenzimidazole, 5-methoxybenzimidazole,
and 5-methoxy-6-methylbenzimidazole, all of which are lower ligands
of cobamides produced by other organisms, are intermediates in the
pathway. The bza gene content of several bacterial and archaeal
genomes is consistent with experimentally determined structures of
the benzimidazoles produced by these organisms, indicating that
these genes can be used to predict cobamide structure. The identifi-
cation of the bza genes thus represents the last remaining unknown
component of the biosynthetic pathway for not only B12 itself, but
also for three other cobamide lower ligands whose biosynthesis was
previously unknown. Given the importance of cobamides in environ-
mental, industrial, and human-associated microbial metabolism, the
ability to predict cobamide structure may lead to an improved ability
to understand and manipulate microbial metabolism.
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Vitamin B12 (cobalamin) is required by the majority of animals,protists, and prokaryotes, although B12 and other cobamide
cofactors are synthesized exclusively by a subset of prokaryotes (1).
Cobalamin is a member of the cobamide family of cofactors that are
composed of a central cobalt ion coordinated by a tetrapyrrolic
corrin ring, an upper ligand, and a lower ligand covalently tethered
to the corrin ring by a nucleotide loop (Fig. 1A) (1). The lower li-
gand of cobalamin is 5,6-dimethylbenzimidazole (DMB). Purines,
phenolic compounds, and other substituted benzimidazoles
have also been found as cobamide lower ligands (2).
Distinct oxygen-requiring (aerobic) and oxygen-sensitive (an-
aerobic) cobamide biosynthesis pathways have been character-
ized, and each contains ∼30 genes (1). The biosynthetic pathway
for DMB remained elusive until the discovery of the bluB gene,
the product of which fragments reduced flavin mononucleotide
(FMNH2) to produce DMB in an oxygen-dependent reaction (3–6).
Currently, the only unidentified genes in the cobamide biosynthesis
pathway are those required for the anaerobic biosynthesis of DMB
and other benzimidazoles (7). Based on previous isotope-label-
ing studies, performed mainly in the anaerobic bacterium
Eubacterium limosum, the biosynthesis of DMB was proposed to
branch from the purine biosynthetic pathway, similar to the py-
rimidine ring of the cofactor thiamin pyrophosphate (Fig. 1B)
(2, 8–15). Here, we sought to identify the genes in Eubacterium
limosum required for the biosynthesis of DMB.
Results
Identification of Putative DMB Biosynthesis Genes Adjacent to
Cobalamin Riboswitches in E. limosum. We searched the pub-
lished genome sequence of E. limosum strain KIST612 (16) for
genes located downstream of the regulatory elements known as
cobalamin riboswitches. These regulatory sequences are com-
monly found adjacent to genes involved in cobamide biosynthesis
and transport, including bluB (3, 17). This analysis showed that the
E. limosum genome contains 13 putative cobalamin riboswitches, of
which 5 are associated with homologs of known cobalamin bio-
synthesis genes (Fig. 2A and SI Appendix, Fig. S1). One riboswitch
sequence is located at the 5′ end of a putative operon containing
five genes of unknown function in addition to a homolog of cobT,
which encodes the first enzyme necessary for the attachment of a
lower ligand base to a cobamide precursor (Fig. 2A) (18). The first
two ORFs in the operon are annotated as thiC, which encodes
the enzyme 4-amino-5-hydroxymethyl-2-methylpyrimidine phosphate
(HMP-P) synthase, an oxygen-sensitive radical S-adenosylmethio-
nine (SAM) enzyme that uses the purine intermediate 5-amino-
imidazole ribotide (AIR) as a substrate for the biosynthesis of the
pyrimidine ring of thiamin pyrophosphate (Figs. 1B and 2A) (8).
The two E. limosum thiC homologs cluster in a phylogenetic clade
together with other thiC homolog pairs found associated with cobT
or other genes involved in B12 biosynthesis or metabolism (Fig. 2B).
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These gene products share 46 and 41% identity with each other and
with ThiC, respectively (SI Appendix, Table S1). We focused our
subsequent functional studies on this genomic locus. Based on the
results described below, we have named these genes bzaABCDE
(for benzimidazole biosynthesis, Fig. 2A).
Heterologous Expression of the bzaABCDE Genes in Escherichia coli
Leads to DMB Biosynthesis. To examine the function of the
E. limosum bza operon, we expressed the bza locus from E. limosum
strain ATCC 10825 on a plasmid in E. coli and cultured the
strain anaerobically. Although E. coli contains an incomplete
cobamide biosynthesis pathway, it possesses the cobUTSC genes
and therefore can form a cobamide from the advanced intermedi-
ate cobinamide (Cbi) (19, 20). In a mutant lacking the metE gene,
E. coli relies on the cobamide-dependent methionine synthase
encoded bymetH (21). An E. coli ΔmetE strain containing the empty
vector attached intracellular purines to exogenously supplied Cbi
to produce two purinyl cobamides, 2-methyladeninylcobamide
(Factor A) and adeninylcobamide (pseudo-B12 or pB12), as
revealed by HPLC analysis of corrinoid extracts (Fig. 3A). These
purinyl cobamides were also detected when the E. limosum cobT
gene was expressed in an E. coli ΔmetE ΔcobT mutant back-
ground, indicating that the cobT gene from the bza operon is
functional (Fig. 3A). Notably, when the E. limosum bza operon
was expressed in the E. coli ΔmetE ΔcobT strain, a cobamide was
formed with a retention time and UV-visible (UV-Vis) spectrum
identical to that of a standard of cyanocobalamin (vitamin B12)
(Fig. 3A and SI Appendix, Fig. S3). 1H-NMR analysis of the
purified cobamide confirmed its identity as cyanocobalamin (SI
Appendix, Fig. S3). Furthermore, this cobamide could support
the growth of Salmonella enterica provided with ethanolamine as
the sole nitrogen source when grown aerobically, a condition that
has been shown to require exogenous B12 (Fig. 3B) (1, 22–24).
To test whether the B12 detected above was the result of de
novo biosynthesis of DMB, E. coli expressing the bza operon was
grown in a medium containing 15N-labeled ammonium chloride
as the sole nitrogen source. A corrinoid extract of this culture
was analyzed by liquid chromatography-tandem mass spectrom-
etry (LC-MS/MS) with multiple reaction monitoring (MRM). A
peak that coelutes with standard cyanocobalamin and corre-
sponding to [15N1,
15N3-DMB]-B12 was observed (top trace),
whereas unlabeled B12 was not detected (middle trace), con-
firming that DMB is synthesized de novo in this E. coli strain
(Fig. 3C). Together, these results demonstrate that expression of
the E. limosum bza operon is sufficient for anaerobic DMB
biosynthesis in E. coli.
Functional Analysis of the Individual bza Genes and DMB Biosynthesis
Intermediates.We next examined the functions of the individual bza
genes by constructing a series of plasmids containing different
subsets of the genes in the operon. These plasmids were introduced
into the E. coli ΔmetE ΔcobT or the E. coli ΔmetE strain. LC-MS
analysis of the corrinoids extracted from these strains showed that
bzaA and bzaB were required together for the formation of the first
Fig. 1. Vitamin B12 structure and the labeling
pattern of DMB. (A) Structure of cyanocobalamin
(vitamin B12). Cbi and the lower ligand DMB are in-
dicated. (B) AIR is a branch point in the biosynthesis
of thiamin (8), purines (27), and benzimidazoles (as
shown in this study). The symbols represent the origins
of atoms in each product: ●, formyltetrahydrofolate;
#, glutamine; *, glycine; shaded circle, erythrose
4-phosphate or threose; ▪, methionine.
Fig. 2. Identification of the E. limosum bza genes. (A) E. limosum bza operon.
Arrows represent ORFs. Gene locus tags as given by the National Center for
Biotechnology Information (NCBI) database are shown below, and new gene
names are shown above. Protein annotations in the NCBI database are shown
in parentheses. (B) Phylogenetic tree of BzaA, BzaB, BzaF, and ThiC. BzaA,
BzaB, and BzaF homologs are in black (BzaF is discussed below); ThiC homologs
are in gray. Boldface indicates experimentally verified functions. An extended
version of this figure is shown in SI Appendix, Fig. S2.
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intermediate, 5-hydroxybenzimidazole (5-OHBza), because strains
expressing either gene alone were similar to a control strain
containing the empty vector (Fig. 4 and SI Appendix, Fig. S4A).
Expression of bzaC, which encodes a putative SAM-dependent
methyltransferase, is required for methylation of this in-
termediate to form 5-methoxybenzimidazole (5-OMeBza) (Fig. 4
and SI Appendix, Fig. S4). The formation of the intermediate
5-methoxy-6-methylbenzimidazole (5-OMe-6-MeBza) requires bzaD,
and the final step, formation of DMB, additionally requires bzaE
(Fig. 4). These results demonstrate that each of the bza genes is
necessary for DMB biosynthesis. When these strains were cultured
under aerobic conditions, benzimidazole formation was signifi-
cantly reduced, suggesting that one or more oxygen-sensitive steps
are involved in this pathway (SI Appendix, Fig. S4B). However,
when bzaC was expressed alone in the presence of 5-OHBza, a
small amount of 5-OMeBza was formed under both anaerobic and
aerobic conditions, indicating that this step is likely not oxygen-
sensitive (SI Appendix, Fig. S4B). Together, these results define
the roles of each bza gene and the major intermediates in the
pathway leading to the formation of DMB.
AIR Is the Precursor of 5-OHBza, the First Intermediate in DMB
Biosynthesis. The results shown above demonstrate that 5-OHBza,
the first benzimidazole intermediate, is formed from metabolites
available in the E. coli cell. Given that (i) the imidazole ring of
DMB shares a common metabolic origin with that of purines
(2, 13), (ii) BzaA and BzaB are homologous to ThiC, and
(iii) the ThiC enzyme uses the purine intermediate AIR as a
substrate (8), we predicted that B12 would not be produced in
an E. coli strain lacking AIR (Fig. 1B). Indeed, expression of
the bza genes in an E. coli ΔmetE ΔcobT strain lacking the AIR
synthase encoded by the purM gene (25) did not lead to B12
production, suggesting that AIR is a required precursor of DMB
(Fig. 5A). In contrast, deletion of purK, which functions in the
conversion of AIR to the subsequent intermediate in purine bio-
synthesis, N5-carboxyaminoimidazole ribonucleotide (NCAIR),
had no effect on B12 production (Fig. 5A) (26, 27). These results
identify AIR as a precursor in the anaerobic B12 biosynthesis
pathway. Thus, AIR is a branch point in the biosynthesis of pu-
rines, thiamin, and DMB (Fig. 1B).
In addition to AIR, threose or erythrose was proposed to be a
precursor for benzimidazole biosynthesis in E. limosum and
Clostridium barkeri (Fig. 1B) (12, 14). To identify the complete set
of substrates required for the biosynthesis of 5-OHBza, we puri-
fied a homolog of BzaA and BzaB from Geobacter sulfurreducens
and assayed its activity in vitro. In G. sulfurreducens and several
other bacteria, a single thiC homolog (hereafter called bzaF) is
located adjacent to cobamide biosynthesis genes (Fig. 6) and is
found in a phylogenetic clade distinct from ThiC, BzaA, and BzaB
(Fig. 2B). We hypothesized that this gene would also function in
5-OHBza biosynthesis. We found that, like ThiC, purified BzaF
protein contains an iron–sulfur (Fe–S) cluster and uses SAM as a
cofactor. Unexpectedly, when only SAM and AIR were provided
to BzaF, a product with a retention time, mass, and UV-Vis
Fig. 3. Characterization of the E. limosum bza operon in E. coli. (A) HPLC
chromatograms of corrinoid extracts of E. coli strains expressing E. limosum
genes. Peaks confirmed by LC-MS/MS are labeled; an unidentified peak is
marked with an asterisk (*). Standards are shown in gray. All cobamides shown
are in their cyanated forms. (B) The bza operon product supports cobalamin-
dependent growth in S. enterica. Growth curves of S. enterica cultured with
ethanolamine as the sole nitrogen source are shown with added cobamide
product of E. coli expressing the E. limosum bza operon (Upper chromatogram in
A, 15.8 min) or the indicated controls. Error bars represent SD of triplicate
samples. (C) The bza operon directs de novo DMB biosynthesis. LC-MS/MS with
MRM analysis is shown for a corrinoid extract of the E. coli metE cobT strain
expressing the E. limosum bza operon grown in media containing 15NH4Cl.
Fig. 4. Analysis of the functions of the individual E. limosum bza genes.
(A) LC-MS/MS analysis of corrinoid extracts. E. coli strains expressing differ-
ent subsets of the genes in the bza operon, as indicated on the Right, were
grown as in Fig. 3A. The bzaA-bzaB plasmid was expressed in an E. coli
ΔmetE background and the remaining constructs in a ΔmetE ΔcobT back-
ground. Standard cobamides are shown in the Lower two traces. (B) Model
for the roles of the bza genes in DMB biosynthesis. The first intermediate,
5-OHBza, is synthesized from AIR (as shown below) by the bzaA and bzaB
gene products. The bzaC gene product methylates 5-OHBza to form 5-OMeBza.
Further methylation by the bzaD gene product converts 5-OMeBza to 5-OMe-
6-MeBza, and bzaE acts next in the conversion of 5-OMe-6-MeBza to DMB.









spectrum identical to that of an authentic standard of 5-OHBza
was observed (Fig. 5 B–D). A detailed mechanistic analysis of
another 5-OHBza synthase (HBI synthase), a homolog of BzaF
from Desulfuromonas acetoxidans, reveals interesting mecha-
nistic parallels with ThiC (28). Thus, similar to thiamin py-
rimidine biosynthesis, AIR is the sole substrate required for
synthesizing 5-OHBza.
bza Genes Are Present in Diverse Bacteria and Archaea and Can
Be Used to Predict Cobamide Structure. Four other substituted
benzimidazoles in addition to DMB have been reported as nat-
urally occurring cobamide lower ligands in cultured anaerobic
bacteria and archaea (SI Appendix, Fig. S5) (2). Our observation
that three of these benzimidazoles are intermediates in the DMB
biosynthetic pathway in E. limosum prompted us to examine
whether homologs of the bza genes might be present in the ge-
nomes of other organisms that synthesize benzimidazolyl coba-
mides. Indeed, we found that the genomes of more than 25
bacteria and archaea contained putative bza operons (Fig. 6 and
SI Appendix, Fig. S6). These organisms are phylogenetically di-
verse and are found in a variety of different environments. In the
case of Acetobacterium woodii, which is reported to produce B12,
homologs of all of the bza genes are present and are arranged
similarly to the E. limosum bza operon, suggesting that these
genes also function in DMB production (Fig. 6) (29). Several
other genomes were found in which a subset of the bza genes was
present. In each of the organisms previously shown to produce a
benzimidazolyl cobamide, the set of bza genes present in the
genome was predictive of the structure of the cobamide pro-
duced (SI Appendix, Fig. S6). We further tested the ability of
genome analysis to predict cobamide production by analyzing the
cobamides synthesized by G. sulfurreducens. This bacterium has
been shown to produce a cobamide, but the structure has not
been determined (30). Because the genome of G. sulfurreducens
contains bzaF but no other bza gene homologs, we expected it to
produce [5-OHBza]Cba. Indeed, LC-MS analysis of a corrinoid
extract from a G. sulfurreducens culture showed the production
of [5-OHBza]Cba as the major corrinoid species (SI Appendix,
Fig. S7). In addition, [5-OMeBza]Cba, the cobamide previously
reported to be produced by Moorella thermoacetica, was formed in
an E. coli strain expressing the M. thermoacetica bza operon,
which contains homologs of bzaA, bzaB, cobT, and bzaC (SI
Appendix, Fig. S8) (31). Thus, we have identified not only the
complete set of genes required for DMB biosynthesis in E. limosum
and other B12-producing anaerobes, but also those required for
the biosynthesis of other cobamide-associated benzimidazoles.
Discussion
Although the B12 biosynthetic pathway has been studied for
several decades, resulting in the identification of over 40 genes
involved in the anaerobic and/or aerobic biosynthesis pathways,
the genes required for the anaerobic biosynthesis of the lower
ligand remained elusive until now. With the present discovery,
we have uncovered the last unknown component of the bio-
synthetic pathway for B12.
Despite the lack of phylogenetic or enzymatic commonalities
between the anaerobic and aerobic routes for DMB production,
some parallels exist between the two pathways. First, both the
bza genes and bluB are commonly found downstream of co-
balamin riboswitches and clustered with B12 biosynthesis genes in
many bacterial genomes (3, 17) (SI Appendix, Fig. S6), suggesting
a common mode of regulation of lower ligand biosynthesis and
attachment. Second, both BzaA/B/F and BluB use the same
substrate and cofactors as closely related enzymes—ThiC and
nitroreductases, respectively—yet carry out a novel reaction (4, 8).
It is interesting to note that, unlike the other components of the
cobamide biosynthetic pathway, DMB biosynthesis has appar-
ently evolved independently twice, underscoring the importance
of DMB as a lower ligand. It remains unclear why some organ-
isms synthesize benzimidazoles exclusively for use as cobamide
lower ligands, given that lower ligands of the purine and phenolic
classes are derived from other metabolic pathways.
The discovery of the anaerobic bza genes and analysis of their
individual roles sheds light on several previously unresolved as-
pects of anaerobic benzimidazole biosynthesis. First, prior feeding
studies with labeled substrates in E. limosum suggested that this
pathway branches from the purine biosynthetic pathway; the
present study pinpoints AIR as the direct precursor for 5-OHBza.
Fig. 5. AIR is the direct precursor of 5-OHBza.
(A) LC-MS/MS analysis of corrinoid extracts of purine
biosynthesis mutants. The indicated E. coli strains
were grown with Cbi and 15NH4Cl, and corrinoid
extracts were analyzed for the presence of [15N1,
15N3-DMB]-B12 (doubly chargedm/z of 679.2, product
ion DMB m/z 149.1). (B) In vitro analysis of 5-OHBza
biosynthesis. HPLC analysis of the in vitro reconsti-
tution reaction of G. sulfurreducens BzaF with AIR,
SAM, and dithionite shows the formation of a product
that coelutes with a standard of 5-OHBza. Control
reactions with one component omitted are also shown.
(C) The extracted ion chromatogram of 5-OHBza (m/z
135.1) from the LC-MS analysis of the in vitro re-
constitution reaction of G. sulfurreducens BzaF with
AIR, SAM, and dithionite. (D) UV-Vis spectroscopy of the
BzaF reaction product. The HPLC-purified G. sulfurre-
ducens BzaF reaction product is overlaid with that of a
standard sample of 5-OHBza.
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Surprisingly, four carbon atoms from the ribose moiety of AIR
are incorporated into the benzene ring component of DMB.
Prior labeling studies implicated erythrose and threose as
precursors of these carbon atoms, suggesting that the ribose
moiety of AIR can be formed from these four-carbon sugars in
E. limosum (12, 14). Second, our work agrees with feeding
studies with 13C-labeled benzimidazoles that implicated 5-
OHBza as the precursor of all other benzimidazoles in E. limosum
and M. thermoacetica (13, 32). However, we also show that 5-
OMeBza and 5-OMe-6-MeBza, which were previously suggested to
be side products of the pathway, are intermediates in DMB bio-
synthesis (13). A third insight from those studies was that DMB,
although it is a symmetric molecule, is attached to the nucleotide
loop exclusively via the nitrogen atom derived from glutamine
(Fig. 1B) (10–12, 14, 15). This could mean either that the bond of
this nitrogen to the ribose ring was formed on an asymmetric pre-
cursor or that a close association between enzymes in the pathway
prevents the release of free DMB before phosphoribosylation by
CobT. Because of the proximity of the cobT and bza genes in
numerous genomes (SI Appendix, Fig. S6), we speculate that the
phosphoribosylation step could be coupled to the biosynthesis of
DMB or one of its precursors. Curiously, both BzaD and BzaE
have putative B12-binding domains, suggesting that the final two
methylation steps could occur on a cobamide rather than a free
base. A detailed mechanistic analysis of each of these enzymes will
be required to investigate this further.
Because DMB and other substituted benzimidazoles share a
common biosynthetic pathway, our findings enable the improved
prediction of cobamide biosynthesis based on analysis of genome
sequence. This is especially useful considering the increasing
abundance of microbial genome and metagenome sequence
data, coupled with persistent challenges associated with studying
most microbes in pure culture, as well as the growing recognition
of the role of microbes in human health and the environment.
Given the importance of cobamides in environmental, industrial,
and human-associated microbes, the identification of this path-
way may lead to an enhanced ability to understand and manip-
ulate microbial metabolism.
Materials and Methods
Materials. Cyanocobalamin (vitamin B12), dicyanocobinamide (Cbi), DMB, and
5-OMeBza were purchased from Sigma-Aldrich. 15N-ammonium chloride was
purchased from Cambridge Isotopes Laboratories. 5-OHBza was synthesized
as previously described (33). [5-OHBza]Cba, [5-OMeBza]Cba, [5-OMe-6-MeBza]Cba,
pseudo-B12, and Factor A were purified as described (34).
Bioinformatic Analysis.
Identification of cobalamin riboswitch-regulated operons: Nucleotide sequences of
genomes of interest were searched to identify cobalamin riboswitches using
Infernal v1.1 (35). A covariance model was built using the RF00174 seed
alignment downloaded from Rfam (36) and Infernal’s cmbuild function.
After calibrating the covariance model with the cmcalibrate function, ge-
nomes were searched with the cmsearch function. Positive hits were those
satisfying the default Infernal inclusion threshold of an E-value of 0.01 or
less. The chromosomal locations of the putative cobalamin riboswitches
were visualized and analyzed using the Joint Genome Institute’s Integrated
Microbial Genomes (IMG) web service (37).
Identification of thiC homologs: All archaeal and bacterial genomes of “Fin-
ished” status in IMG’s system as of January 2, 2015, were searched. The
function “pfam01964” was used to carry out a “Function Profile” against all
finished genomes. Genomes with multiple thiC homologs were prioritized
for examination of genomic context of thiC homologs. thiC homologs were
screened to identify those that were contained within the same operon as
cobalamin biosynthesis or transport genes.
Phylogenetic analysis of thiC homologs: The sequences of all thiC homologs from
genomes that had multiple thiC homologs were downloaded from IMG and
aligned to Pfam’s PF01946 seed alignment using the “seed” option in Mul-
tiple Alignment using Fast Fourier Transform (MAFFT) v7.2 (38). The multiple
sequence alignment was edited in Geneious v5.5 (39) to remove ambigu-
ously aligned amino acids and large end gaps. After this editing step, se-
quences whose amino acid count was less than 60% of the length of the
entire multiple sequence alignment were removed from the analysis. Seed
sequences that were duplicates of sequences downloaded from IMG were
also removed before phylogenetic analysis. The alignment was uploaded to
the Cyberinfrastructure for Phylogenetic Research (CIPRES) web portal, and a
maximum-likelihood (ML) tree was reconstructed using RAxML v8.1 (40). The
amino acid substitution matrix used was the JTT matrix (41), with the Γ
model of rate heterogeneity. RAxML’s rapid bootstrap was performed with
1,000 replicates, and the best-scoring ML tree was saved.
Genetic and Molecular Techniques. E. coli strains ΔcobT::KanR (JW1969-1),
ΔmetE::KnR (JW3805-1), ΔpurM::KanR (JW2484-1), and ΔpurK::KanR (JW0511-1)
were obtained from the Keio collection (42). The mutations were introduced
into E. coli strain MG1655 by P1 transduction (43). For construction of double
and triple mutants, the KanR cassette was removed by recombination of
flanking FRT sites as described (44). Double and triple mutants were con-
structed by P1 transduction of the KanR cassette into deletion strains.
The E. limosum and M. thermoacetica bza operons were cloned into plas-
mid pTH1227 (45) by Gibson assembly (46) following PCR on genomic DNA
with primers P604F/P619R (E. limosum) and P615F/P616R (M. thermoacetica).
Additional constructs were created similarly with the primers in SI Appendix,
Table S2. Strains and plasmids are in SI Appendix, Table S3.
The nucleotide sequence of G. sulfurreducens bzaF was synthesized and
cloned into plasmid THT, a pET28 vector with a tobacco etch virus protease
cleavage site for removing the His-tag.
Media and Culture Conditions. E. coli strains containing pTH1227 or its de-
rivatives were grown at 37 °C under anaerobic conditions with 95–98% N2
and 5–2% H2 as headspace gas for 72–144 h in M9 glucose minimal medium
supplemented with 100 μM isopropyl β-D-1-thiogalactopyranoside, 50 μM
freshly prepared FeSO4, 10 nM Cbi, and 25 mg/L tetracycline, unless other-
wise indicated. Strains containing mutations in purK or purM were grown
with 50 nM Cbi, 20 μM inosine, and 20 μM thiamin (unexpectedly, both
strains could grow in the absence of added thiamin, although purM strains
are expected to require thiamin). When indicated, 15NH4Cl was substituted
for unlabeled NH4Cl. For growth of E. coli under aerobic conditions, cultures
were aerated at 250 rpm for 36–96 h. For corrinoid extractions, the strains
were grown in 2-L cultures.
S. enterica serovar Typhimurium strain LT2, G. sulfurreducens PCA,
E. limosum ATCC 10825, and M. thermoacetica ATCC 39073 were cultivated
as described in SI Appendix, SI Methods.
Corrinoid Extraction and HPLC Analysis. Corrinoids were extracted from cell
pellets, purified, and analyzed as described in SI Appendix, SI Methods.
Chemical Analysis. The UV-Vis spectra were collected during HPLC analysis
using Agilent ChemStation software. Samples were further characterized on
an Agilent 6410 liquid chromatograph-triple quadrupole mass spectrometer
using an Agilent Zorbax SB-Aq column to identify cobamides based on their
characteristic transitions and retention times (34). For corrinoid extracts from
strains grown in 15NH4Cl, the MS method was modified to detect the
Fig. 6. The bza genes present in an organism are predictive of the coba-
mide that it produces. Genetic loci of organisms identified from the JGI
database that contain bza genes adjacent to cobamide biosynthesis or me-
tabolism genes are shown (an extended list is presented in SI Appendix, Fig.
S6). The benzimidazole lower ligand that these organisms are predicted to
synthesize is shown on the Right. The predictions verified in previous studies
are labeled with an asterisk (*). Those verified by analysis of corrinoids (#),
biochemical activity (@), or heterologous expression (&) are indicated.









following precursor and product ion transitions, respectively: 679.3, 149.1
(B12); 673.3, 137.1 ([5-OHBza]Cba); 680.3, 151.1 ([5-OMeBza]Cba); 687.3,
165.1 ([5-OMe-6-MeBza]Cba); 675.3, 141.1 (pseudo-B12); 682.3, 155.1 (Factor A).
For NMR analysis, cobamides were purified by HPLC using an Agilent
1200 series fraction collector. A standard sample of cyanocobalamin and a
blank buffer sample were also collected under the same HPLC purification
conditions. These samples were analyzed using a Bruker Biospin Avance II
900 MHz NMR spectrometer equipped with a TXI cryoprobe accessory at the
California Institute for Quantitative Biosciences Berkeley core facility.
Biochemical Characterization of G. sulfurreducens BzaF. His-tagged G. sulfur-
reducens PCA BzaF was expressed and purified as described in SI Appendix,
SI Methods.
Enzymatic Assays for LC-MS and HPLC Purification of 5-OHBza. Purified
G. sulfurreducens BzaF (120 μM) was incubated with dithionite (10 mM),
AIR (3 mM), and SAM (5 mM) at room temperature for 60 min. Controls
included reactions lacking either AIR, SAM, dithionite, or the enzyme.
The protein was removed with 10-kDa cutoff filters, and the filtrate was
analyzed by HPLC and LC-MS.
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